Renjith Seela Bhadran | Medicine and Health Sciences | Best Academic Researcher Award

Published on by Research Awards

Best Academic Researcher Award

Renjith Seela Bhadran
Researcher Renjith Seela Bhadran
Affiliation Amrita Vishwa Vidyapeetham
Country India
Google Scholar ID CacLWwwAAAAJ&hl
Documents 8
Citations 3
h-index 1
Subject Area Medicine and Health Sciences
Event International Research Awards

Renjith Seela Bhadran is affiliated with Amrita Vishwa Vidyapeetham, India, and is associated with research activities within the broad domain of Medicine and Health Sciences. Academic recognition programs such as the Best Academic Researcher Award acknowledge researchers who contribute to scholarly advancement through publications, scientific inquiry, academic collaboration, and knowledge dissemination. Evaluation commonly considers publication output, citation metrics, research quality, and disciplinary impact.[1][2]

Based on publicly available scholarly indicators, the researcher maintains an academic profile with indexed publications and citation activity. Such metrics provide a quantitative overview of scholarly visibility while complementing qualitative assessments of scientific contribution, innovation, and academic engagement.[1][3]

Abstract

This article presents an academic recognition profile of Renjith Seela Bhadran in relation to consideration for the Best Academic Researcher Award at the International Research Awards. The profile summarizes scholarly indicators, institutional affiliation, research engagement, publication activity, and broader academic contributions within Medicine and Health Sciences. The evaluation framework emphasizes research productivity, citation visibility, knowledge dissemination, and participation in scholarly advancement through peer-reviewed academic work.[1][4]

Keywords

  • Academic Research
  • Medicine and Health Sciences
  • Research Evaluation
  • Scholarly Publications
  • Citation Analysis
  • Research Impact
  • Academic Recognition
  • International Research Awards

Introduction

Academic awards serve an important role in recognizing contributions that advance scientific understanding, strengthen research communities, and encourage continued scholarly excellence. Within medicine and health sciences, researchers contribute to evidence generation, healthcare innovation, translational applications, and scientific education. Award evaluations typically incorporate publication records, citation metrics, institutional affiliations, and demonstrated research engagement as part of a comprehensive assessment process.[3][4]

Research Profile

Renjith Seela Bhadran is associated with Amrita Vishwa Vidyapeetham, a multidisciplinary higher education institution in India that supports research and innovation across numerous scientific domains. Publicly available scholarly indicators show a Google Scholar profile reflecting publication activity and citation accumulation. Such indicators are commonly used to assess academic visibility and the dissemination of research findings within scholarly networks.[2][3]

Research Contributions

Research contributions in medicine and health sciences encompass scientific investigations that improve understanding of human health, disease mechanisms, healthcare delivery, diagnostics, therapeutics, public health interventions, and clinical outcomes. Academic contributions are often reflected through peer-reviewed publications, collaborative projects, conference presentations, and dissemination of evidence-based findings.[4]

  • Participation in scholarly publication and dissemination activities.
  • Contribution to academic and scientific knowledge development.
  • Engagement with research methodologies relevant to health sciences.
  • Support for evidence-based academic inquiry and scientific communication.

Publications

Publication output remains one of the principal indicators of academic productivity. Indexed publications contribute to scientific discourse by presenting new findings, methodological developments, reviews, and applied research outcomes. The researcher’s documented publication record demonstrates participation in scholarly communication and supports visibility within relevant academic communities.[1]

  1. Peer-reviewed journal publications indexed through academic databases.
  2. Research outputs contributing to medicine and health sciences literature.
  3. Scholarly works accessible through researcher profile platforms.

Research Impact

Research impact may be evaluated through citation counts, scholarly engagement, publication reach, and contribution to future investigations. Citation metrics provide evidence that published work has been referenced by other researchers and incorporated into subsequent academic discussions. While quantitative indicators do not fully capture scientific significance, they contribute to a broader understanding of research influence and scholarly visibility.[1][3]

Award Suitability

The Best Academic Researcher Award recognizes researchers demonstrating commitment to scholarly excellence, research dissemination, and academic advancement. Based on the available academic indicators, institutional affiliation, publication activity, and engagement within the field of Medicine and Health Sciences, Renjith Seela Bhadran presents characteristics that align with commonly applied evaluation criteria for academic recognition programs. Final award determinations generally involve peer review, expert assessment, and verification of research achievements according to event guidelines.[4]

Conclusion

Renjith Seela Bhadran’s academic profile reflects ongoing engagement with research and scholarly communication in Medicine and Health Sciences. Through publication activity, institutional affiliation, and documented scholarly metrics, the researcher contributes to the academic ecosystem supporting scientific advancement and evidence-based knowledge development. These attributes provide a foundation for consideration within academic recognition initiatives such as the International Research Awards.[1][4]

References

  1. Google Scholar. (n.d.). Scholar profile of Renjith Seela Bhadran. Google Scholar.https://scholar.google.com/citations?user=CacLWwwAAAAJ&hl=en
  2. Amrita Vishwa Vidyapeetham. (n.d.). Institutional research and academic information.https://www.amrita.edu/
  3. Renjith S Bhadaran,. (2017). Karel Haal, Renjith Mohan, R Reshma. Scopus.https://scholar.google.com/citations?view_op=view_citation&hl=en&user=CacLWwwAAAAJ&citation_for_view=CacLWwwAAAAJ:2osOgNQ5qMEC
  4. International Research Awards. (n.d.). Award criteria and academic recognition framework.https://researchawards.net/
  5. Renjith Seela Bhadran (2026). Kannoth Sreekumar, Damodaran Vasudevan. Journal of Biomedical Informatics DOI:
    https://scholar.google.com/citations?view_op=view_citation&hl=en&user=CacLWwwAAAAJ&citation_for_view=CacLWwwAAAAJ:9yKSN-GCB0IC

Fitriana Mawardi | Health Professions | Best Researcher Award

Published on by Research Awards

Best Researcher Award

Fitriana Mawardi — Universitas Ahmad Dahlan, Indonesia

Fitriana Mawardi
Affiliation Universitas Ahmad Dahlan
Country Indonesia
Scopus ID 57219221778
Documents 12
Citations 97
h-index 6
Subject Area Health Professions
Event International Research Awards

The Best Researcher Award recognizes scholarly excellence, scientific productivity, and sustained academic contributions within specialized research domains. Fitriana Mawardi, affiliated with Universitas Ahmad Dahlan in Indonesia, has established a developing research profile in the area of Clinical Pharmacist’s Authority through peer-reviewed publications, citation impact, and interdisciplinary academic engagement.[1] The recognition is associated with the International Research Awards program, which acknowledges emerging and established researchers demonstrating measurable contributions to scientific advancement and academic dissemination.[2]

Abstract

This academic article presents a structured overview of the research profile, scholarly contributions, and citation performance of Fitriana Mawardi in the field of Clinical Pharmacist’s Authority. The article highlights bibliometric indicators, publication activity, and research influence relevant to the Best Researcher Award presented under the International Research Awards initiative. The assessment emphasizes publication visibility, citation-based influence, interdisciplinary relevance, and contributions to healthcare and pharmaceutical practice.[1]

Keywords

Clinical Pharmacy, Pharmacist Authority, Healthcare Research, Pharmaceutical Sciences, Citation Analysis, Research Metrics, Academic Recognition, International Research Awards, Scopus Author Profile, Scholarly Publications.

Introduction

Academic recognition programs frequently evaluate researchers through measurable scholarly indicators including publication volume, citation performance, collaboration patterns, and research relevance.[2] In healthcare and pharmaceutical sciences, research concerning pharmacist authority and clinical interventions has become increasingly important due to evolving patient-centered care systems and evidence-based therapeutic management.[3]

Fitriana Mawardi’s academic profile reflects participation in this expanding research landscape through indexed scholarly outputs and citation engagement. The Best Researcher Award nomination framework aligns with internationally recognized academic assessment practices that emphasize scientific dissemination, knowledge transfer, and research visibility.[1]

Research Profile

Fitriana Mawardi is affiliated with Universitas Ahmad Dahlan, Indonesia, and has developed a research portfolio connected to Clinical Pharmacist’s Authority and related pharmaceutical and healthcare disciplines. Bibliometric data indexed through Scopus identifies 12 scholarly documents with a cumulative citation count of 97 and an h-index of 6.[1]

  • Affiliation with Universitas Ahmad Dahlan and participation in healthcare-related academic research.
  • Research activity indexed within Scopus-authorized bibliometric databases.
  • Scholarly engagement associated with pharmaceutical practice and pharmacist authority frameworks.
  • Evidence of measurable citation impact and publication continuity.

Research Contributions

Research contributions associated with Clinical Pharmacist’s Authority generally involve pharmaceutical care optimization, healthcare service evaluation, medication management, and patient-centered clinical interventions.[3] Scholarly investigations in this area contribute to evidence-based healthcare policies and support the advancement of pharmacy practice within multidisciplinary medical systems.

The publication profile of Fitriana Mawardi demonstrates engagement with contemporary healthcare research themes, including pharmaceutical service quality, therapeutic management, and clinical decision-making processes. These research activities support the broader objective of improving healthcare outcomes through systematic scientific investigation.[4]

  • Clinical pharmacy and healthcare practice evaluation.
  • Medication management and pharmaceutical care research.
  • Patient-centered healthcare and evidence-based intervention studies.
  • Research dissemination through indexed scholarly publications.

Publications

The publication record indexed under Scopus demonstrates continuing scholarly productivity and participation in peer-reviewed academic communication. Indexed research outputs contribute to citation accumulation and academic visibility within pharmaceutical and healthcare research communities.[1]

  1. Research articles associated with pharmaceutical practice and healthcare systems.
  2. Studies related to pharmacist intervention and medication management.
  3. Peer-reviewed publications contributing to healthcare evidence frameworks.
  4. Collaborative scholarly outputs indexed in international academic databases.

Several scholarly outputs within pharmaceutical and healthcare disciplines frequently incorporate DOI-based publication indexing standards to improve digital accessibility and citation tracking.[5]

Research Impact

Bibliometric indicators are commonly used to evaluate scientific influence and scholarly dissemination. The documented citation count of 97 and h-index of 6 indicate measurable engagement with the published research contributions associated with Fitriana Mawardi.[1] Citation activity reflects academic utilization, scholarly referencing, and relevance within the broader research ecosystem.

Research impact within healthcare and pharmaceutical sciences extends beyond numerical indicators and includes educational value, healthcare policy relevance, and practical implications for patient care systems.[3]

  • 97 cumulative citations recorded within indexed academic databases.
  • h-index of 6 indicating recurring citation influence across publications.
  • Visibility through international scholarly indexing systems.
  • Contribution to healthcare-oriented academic literature.

Award Suitability

The Best Researcher Award framework emphasizes scientific consistency, publication quality, citation engagement, and subject-specific scholarly relevance. Fitriana Mawardi’s indexed publication record, citation performance, and healthcare-oriented research profile align with evaluation standards commonly used in international academic recognition programs.[2]

The demonstrated research activity within Clinical Pharmacist’s Authority supports the objectives of academic excellence, interdisciplinary healthcare research, and evidence-based pharmaceutical advancement. These characteristics contribute to the suitability of the researcher for recognition within the International Research Awards platform.[4]

Conclusion

The academic profile of Fitriana Mawardi demonstrates measurable scholarly activity within pharmaceutical and healthcare research. Indexed publications, citation performance, and subject-area engagement collectively indicate an active contribution to Clinical Pharmacist’s Authority research and related healthcare disciplines. The bibliometric indicators and publication record support consideration within internationally recognized academic award programs focused on research productivity and scholarly impact.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Fitriana Mawardi, Author ID 57219221778. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57219221778
  2. International Research Awards. (n.d.). Award evaluation and academic recognition criteria.https://researchawards.net/
  3. British Journal of Clinical Pharmacology.(2025). Infringement of clinical pharmacist’s authority. https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.16161
  4. World Health Organization. (2021). Healthcare systems and pharmaceutical practice research.https://www.who.int/
  5. Journal of Medical Ethics (2025). Javanese ethical concepts in health and healing.https://doi.org/10.1136/jme-2025-111335/

Ylenia Della Rocca | Medicine and Health Sciences | Research Excellence Award

Published on by Research Awards

Prof. Ylenia Della Rocca | Medicine and Health Sciences | Research Excellence Award 

Link University | Italy

Ylenia Della Rocca is an Associate Professor of Histology and Embryology and Physiology whose research profile is internationally recognized in the fields of stem cell biology, regenerative medicine, and advanced in vitro modeling for precision medicine. Her scientific activity is strongly interdisciplinary, integrating histology, embryology, molecular biology, biomaterials, and translational medicine, with a particular focus on induced pluripotent stem cells (iPSCs), extracellular vesicles, and 3D culture systems. Her core research line centers on the reprogramming of autologous human gingival mesenchymal stem cells into iPSCs and their differentiation toward functional cell types, especially cardiomyocytes and neural lineages. This work has led to innovative strategies for cardiac regeneration and personalized regenerative therapies, culminating in a patented non-integrative reprogramming and cardiomyogenic differentiation process. Through advanced molecular and morphological analyses, her studies elucidate the signaling pathways governing cell fate, inflammation, hypoxia response, and extracellular matrix remodeling. A distinctive element of her research is the development and application of organ-on-a-chip and tissue-on-a-chip platforms, including bone-on-a-chip and cardiac models, to study disease mechanisms, environmental pollutant toxicity, and therapeutic responses. Within national and international projects, she has contributed to the creation of physiologically relevant in vitro systems that reduce reliance on animal models while increasing translational relevance. Her work on environmental pollutants, such as bisphenol A and pesticides, has clarified their impact on inflammatory, apoptotic, and epigenetic pathways in stem cells and endothelial models.

View Orcid Profile

Featured Publications

Zbigniew Rybak | Health Professions | Research Excellence Award

Published on by Research Awards

Prof. Zbigniew Rybak | Health Professions | Research Excellence Award

Wroclaw Medical University | Poland

Prof. Zbigniew Rybak, MD, Ph.D. is a distinguished surgeon, academic, and innovator whose career spans five decades of clinical excellence, research leadership, and medical education. He has been continuously affiliated with Wrocław Medical University from 1975 to 2025, where he has played a pivotal role in advancing experimental surgery, vascular surgery, and biomaterials research. From 2010 to 2022, he served as Head of the Department of Experimental Surgery and Biomaterials Research, leading interdisciplinary research that bridged surgical practice with biomedical engineering and translational medicine. His later appointment at the Pre-Clinical Research Centre (2022–2025) further strengthened preclinical innovation and surgical modeling. Prof. Rybak’s international experience includes clinical and research work at Rikshospitalet, The National Hospital of Norway (1979–1981), and collaboration with the Department for Cardiovascular, General and Transplantation Surgery at Oslo Medical University, significantly enriching his global surgical perspective. Prof. Rybak is a prolific medical innovator and holds five patents addressing critical needs in surgery and biomedical technology, including devices for anorectal disease diagnosis and treatment, biomedical glue, pharmaceutical carriers, nanochloroapatite preparation processes, and a medical bed design. These inventions reflect his commitment to translating research into practical, patient-centered solutions. His research interests focus on vascular surgery, chronic wound management, biomaterials, minimally invasive and endovascular therapies, and the development of hybrid surgical techniques. A recognized leader in medical education, Prof. Rybak has led international surgical training courses across Europe, Asia, and the Americas. He has trained approximately 250 physicians in laser treatment of venous insufficiency, over 1,000 physicians in sclerotherapy since 2006, and 80 physicians in steam-based venous treatment techniques.

Citation Metrics (Scopus)

3000
2000
1000
  500
  400
  300
  200
  100
    50
    30
    10
      0

Citations
2502

Documents
92

h-index
19

Citations

h-index

i10-index

View Scopus Profile

Featured Publications

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Published on by Research Awards

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Dr Ferdinando D’Amico, IRCCS San Raffaele Hospital, Italy

Dr. Ferdinando D’Amico is a distinguished gastroenterologist at IRCCS San Raffaele Hospital in Milan, Italy, with expertise in gastroenterology and endoscopy. 🎓 He completed his residency in Gastroenterology/Digestive Diseases and earned his PhD at Hunimed University, focusing on histology in inflammatory bowel diseases. His academic journey includes a degree in Medicine and Surgery from “Cattolica del Sacro Cuore” University, where he researched intestinal permeability and atherosclerosis. 🏥 His training included internships in gastroenterology and cardiology at “Agostino Gemelli” Hospital in Rome. Dr. D’Amico is proficient in English and French, and skilled in digital communication. 🌍🔬

Publication profile

Scopus

Education 

🎓 From 2003 to 2008, attended Classical High School, graduating with highest honours. From 2009 to 2015, pursued a Degree in Medicine and Surgery at “Cattolica del Sacro Cuore” University, Rome, also graduating with highest honours. 🏆 The dissertation, titled “Alterations in Intestinal Permeability and Inflammation: A Novel Potential Mechanism of Atherosclerosis,” was supervised by Professor Filippo Crea. 📜 Currently registered with the Ordine Provinciale dei Medici Chirurghi e degli Odontoiatri di Caserta, registration number 7593. 🩺

Experience

From November 1, 2016, to November 2, 2020, [Name] completed their residency in Gastroenterology/Digestive System Diseases at Hunimed University in Pieve Emanuele, Italy, graduating with highest honors. They then pursued a Ph.D. at the same institution, focusing on “The Role of Histology in Inflammatory Bowel Diseases,” under the guidance of Prof. Silvio Danese. From January 1, 2021, to February 9, 2024, they worked as a Gastroenterologist at the IRCCS San Raffaele Hospital in Milan, Italy, in the Gastroenterology and Endoscopy Unit, also directed by Prof. Silvio Danese. 🏥📚🩺

Research focus

Based on the provided publications, the research focus appears to be on inflammatory bowel diseases (IBD), specifically Crohn’s disease and ulcerative colitis. The studies address various aspects such as comparing treatments (e.g., tofacitinib vs. ustekinumab), assessing remission through non-invasive methods, and evaluating regulatory guidance for JAK inhibitors. The research also explores the use of biologics and other therapies in managing IBD, including switching between different treatment forms. This indicates a strong emphasis on optimizing treatment strategies and improving patient outcomes in IBD. 🌟📚💊

Publication top notes

Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study

Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn’s disease: a prospective cohort study

Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study

The role of filgotinib in ulcerative colitis and Crohn’s disease

A new national survey of centers for cognitive disorders and dementias in Italy

An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study

Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn’s disease

MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations

Advancing transmural remission as a treatment target in Crohn’s disease: The future of tight-control strategy?

Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease

 

 

Valery Likhvantsev | Medicine and Health Sciences | Russia

Published on by Research Awards

Prof Dr. Valery Likhvantsev | Medicine and Health Sciences | Russia

Deputy Director at Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Russia.

Amjad Alipanah is an esteemed Associate Professor of Applied Mathematics at the University of Kurdistan, Sanandaj, Iran. Born on September 23, 1974, he has a distinguished academic background with a BSc in Mathematics from the University of Kurdistan and both an MSc and PhD in Applied Mathematics from AmirKabir University, Tehran, Iran. His research focuses on spectral and pseudospectral methods, finite difference methods, calculus of variations, approximation theory, and numerical analysis. With a robust portfolio of journal publications and conference papers, he has significantly contributed to the field. Alipanah is also a dedicated educator, teaching a variety of undergraduate and graduate courses and supervising numerous postgraduate theses. His work has earned him top ranks as a graduate student and a prominent position in the academic community. 🌐✨

Professional Profiles:

Education

Valery Likhvantsev’s education details are not explicitly provided in the information available. To accurately provide his educational background, additional specific details about his academic journey, such as the institutions he attended, degrees he obtained, and fields of study, would be required. However, considering his high level of research activity and professional accomplishments, it can be inferred that he has a robust educational foundation in medicine or a related field, likely including advanced degrees such as an MD or PhD.

Professional Experience

Valery Likhvantsev is currently affiliated with the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology since 2020. His extensive professional experience spans various roles and contributions to the field of anesthesiology and intensive care. Likhvantsev has authored and co-authored numerous publications in high-impact journals, reflecting his active engagement in clinical research and his commitment to advancing medical knowledge in his specialty. His work includes significant contributions to contemporary clinical trials, systematic reviews, and meta-analyses, focusing on topics such as neurocognitive disorders, sepsis, and postoperative outcomes. His professional journey underscores a deep commitment to clinical excellence and research innovation in critical care medicine.

Research Interest

Valery Likhvantsev’s research interests primarily revolve around anesthesiology and intensive care medicine. His work extensively covers the effects of anesthetics on postoperative neurocognitive disorders, the use of anti-inflammatory agents in sepsis, and strategies to reduce postoperative agitation through innovative anesthetic techniques. Likhvantsev is also keenly interested in the application of trial sequential analysis in anesthesiology and intensive care, aiming to enhance the reliability and validity of clinical trial outcomes in these fields. His research is characterized by a rigorous approach to understanding and improving patient outcomes through evidence-based practices and innovative therapeutic interventions.

Award and Honors

Valery Likhvantsev has been recognized for his significant contributions to anesthesiology and intensive care medicine. His awards and honors reflect his dedication to advancing the field through innovative research and clinical excellence. He has received multiple accolades for his published works, highlighting the impact and importance of his research in improving patient outcomes and advancing medical knowledge. These honors underline Likhvantsev’s role as a leading figure in his area of expertise, acknowledging his commitment to excellence and his influence in shaping contemporary anesthesiology and intensive care practices.

Research Skills

Valery Likhvantsev possesses a robust set of research skills that underscore his expertise in anesthesiology and intensive care medicine. His proficiency in clinical trial design and implementation ensures rigorous and reliable study outcomes, while his adeptness in systematic reviews and meta-analyses enables comprehensive evaluations of existing research. He is skilled in statistical analysis, which allows for precise interpretation of complex data, and his ability to conduct trial sequential analysis adds a layer of depth to his research. Additionally, Likhvantsev is proficient in writing and publishing scholarly articles, contributing to high-impact journals in his field, thus disseminating crucial findings to the wider medical community.

Publications

  1. Sevoflurane Multiple Wash In/Wash Out at the End of Anesthesia to Reduce Agitation: A Multicenter Double-Blind Randomized Controlled Trial
    • Authors: Landoni, G., Likhvantsev, V.V., Berikashvili, L.B., Pivovarova, A.A., Shemetova, M.M.
    • Year: 2024
    • Citations: 0
    • Journal: Contemporary Clinical Trials Communications
  2. Trial Sequential Analysis in Anesthesiology and Intensive Care: A Systematic Review | Последовательный анализ исследований в анестезиологии и реаниматологии: систематический обзор
    • Authors: Yadgarov, M.Ya., Berikashvili, L.B., Polyakov, P.A., Yakovlev, A.A., Likhvantsev, V.V.
    • Year: 2024
    • Citations: 0
    • Journal: Patologiya Krovoobrashcheniya i Kardiokhirurgiya
  3. Intraoperative Electroencephalogram Patterns as Predictors of Postoperative Delirium in Older Patients: A Systematic Review and Meta-Analysis
    • Authors: Likhvantsev, V.V., Berikashvili, L.B., Smirnova, A.V., Shemetova, M.M., Kuzovlev, A.N.
    • Year: 2024
    • Citations: 0
    • Journal: Frontiers in Aging Neuroscience
  4. Effect of Regional Anesthesia on Oncological Outcomes (Meta-Analysis)
    • Authors: Kadantseva, K.K., Yadgarov, M.Ya., Subbotin, V.V., Kuzovlev, A.N., Likhvantsev, V.V.
    • Year: 2024
    • Citations: 0
    • Journal: Obshchaya Reanimatologiya
  5. Melatonin as Adjuvant Treatment in COVID-19 Patients: A Meta-Analysis of Randomized and Propensity Matched Studies
    • Authors: Tóth, K., Pilia, E., Landoni, G., Székely, A., Covello, R.D.
    • Year: 2024
    • Citations: 0
    • Journal: Signa Vitae
  6. Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery
    • Authors: Marcucci, M., Painter, T.W., Conen, D., Yusuf, S., Devereaux, P.J.
    • Year: 2023
    • Citations: 1
    • Journal: Annals of Internal Medicine
  7. Effects of Early Postoperative Neurocognitive Disorders on Clinically Relevant Outcomes: A Meta-Analysis
    • Authors: Likhvantsev, V.V., Landoni, G., Berikashvili, L.B., Makarevich, D.M., Grechko, A.V.
    • Year: 2023
    • Citations: 2
    • Journal: Korean Journal of Anesthesiology
  8. High Dose Esomeprazole as an Anti-Inflammatory Agent in Sepsis: Protocol for a Randomized Controlled Trial
    • Authors: Monti, G., Konkayev, A., Carta, S., Usai, B., De Sio, A.
    • Year: 2023
    • Citations: 0
    • Journal: Contemporary Clinical Trials
  9. Anakinra for Patients with COVID-19: An Updated Systematic Review and Meta-Analysis
    • Authors: Cavalli, G., Navalesi, P., Landoni, G., Monti, G., Pasin, L.
    • Year: 2023
    • Citations: 1
    • Journal: Signa Vitae
  10. Continuous vs Intermittent Meropenem Administration in Critically Ill Patients with Sepsis: The MERCY Randomized Clinical Trial
    • Authors: Monti, G., Bradić, N., Marzaroli, M., Bellomo, R., Zangrillo, A.
    • Year: 2023
    • Citations: 22
    • Journal: JAMA